Overview
NTHL1-related polyposis (also called NTHL1-associated polyposis or NAP) is a rare inherited condition that increases the risk of developing multiple polyps in the colon and rectum, as well as certain cancers. It is caused by changes (mutations) in both copies of the NTHL1 gene, which normally helps repair damage to DNA. When this gene does not work properly, errors build up in the DNA of cells, especially in the lining of the colon, leading to the growth of adenomatous polyps — small growths that can become cancerous over time if not removed. People with NTHL1-related polyposis typically develop between 10 and 100 colorectal polyps, usually during adulthood. Beyond colorectal cancer, there is also an increased risk of other cancers, including breast cancer, endometrial (uterine) cancer, bladder cancer, skin tumors (particularly basal cell carcinomas), and possibly other tumor types. The condition was only recently described, so our understanding is still growing. Treatment focuses on regular surveillance with colonoscopies to find and remove polyps before they become cancerous. Surgery to remove part or all of the colon may be needed if polyps are too numerous to manage with colonoscopy alone. Screening for other associated cancers is also recommended. Early detection through genetic testing in at-risk families can significantly improve outcomes by allowing surveillance to begin before cancer develops.
Also known as:
Key symptoms:
Multiple polyps in the colon and rectumColorectal cancerBreast cancerEndometrial (uterine) cancerSkin tumors, especially basal cell carcinomasBladder cancerBlood in the stoolChanges in bowel habitsAbdominal pain or crampingUnexplained weight lossFatigue from anemia due to chronic blood lossHead and neck tumors (less common)
Clinical phenotype terms (15)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for NTHL1-related polyposis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for NTHL1-related polyposis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for NTHL1-related polyposis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to NTHL1-related polyposis.
Community
No community posts yet. Be the first to share your experience with NTHL1-related polyposis.
Start the conversation →Latest news about NTHL1-related polyposis
No recent news articles for NTHL1-related polyposis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How often should I have a colonoscopy, and when should I start?,What other cancers am I at increased risk for, and what screening do I need?,Should my siblings and other family members be tested for NTHL1 mutations?,Are there any medications or lifestyle changes that could help reduce my polyp or cancer risk?,At what point would you recommend surgery to remove part of my colon?,How will this diagnosis affect my children — what is their risk of being carriers or affected?,Are there any clinical trials or new treatments being studied for this condition?
Common questions about NTHL1-related polyposis
What is NTHL1-related polyposis?
NTHL1-related polyposis (also called NTHL1-associated polyposis or NAP) is a rare inherited condition that increases the risk of developing multiple polyps in the colon and rectum, as well as certain cancers. It is caused by changes (mutations) in both copies of the NTHL1 gene, which normally helps repair damage to DNA. When this gene does not work properly, errors build up in the DNA of cells, especially in the lining of the colon, leading to the growth of adenomatous polyps — small growths that can become cancerous over time if not removed. People with NTHL1-related polyposis typically deve
How is NTHL1-related polyposis inherited?
NTHL1-related polyposis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does NTHL1-related polyposis typically begin?
Typical onset of NTHL1-related polyposis is adult. Age of onset can vary across affected individuals.